02.04.2014
- The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's...
27.01.2014
- Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...
12.07.2013
- Britain's MHRA drug regulator has halted the sale of 16 medicines made by Wockhardt after it identified manufacturing deficiencies at the Indian group's Waluj factory. Though the...
03.06.2013
- CPhI Worldwide, organised by UBM Live, announces the founding members of its expert industry panel who are set to collectively assess the changes taking place across the industry...
